Search Page

1

Cite

Share

Targeting the EGFR pathway for cancer therapy.

Johnston JB, Navaratnam S, Pitz MW, Maniate JM, Wiechec E, Baust H, Gingerich J, Skliris GP, Murphy LC, Los M. Johnston JB, et al. Among authors: skliris gp. Curr Med Chem. 2006;13(29):3483-92. doi: 10.2174/092986706779026174. Curr Med Chem. 2006. PMID: 17168718 Review.

Cite

Share

2

Cite

Share

The relevance of phosphorylated forms of estrogen receptor in human breast cancer in vivo.

Murphy LC, Skliris GP, Rowan BG, Al-Dhaheri M, Williams C, Penner C, Troup S, Begic S, Parisien M, Watson PH. Murphy LC, et al. Among authors: skliris gp. J Steroid Biochem Mol Biol. 2009 Mar;114(1-2):90-5. doi: 10.1016/j.jsbmb.2009.01.017. Epub 2009 Feb 6. J Steroid Biochem Mol Biol. 2009. PMID: 19429437 Review.

Cite

Share

3

Cite

Share

Potential role of estrogen receptor alpha (ERalpha) phosphorylated at Serine118 in human breast cancer in vivo.

Murphy LC, Weitsman GE, Skliris GP, Teh EM, Li L, Peng B, Davie JR, Ung K, Niu YL, Troup S, Tomes L, Watson PH. Murphy LC, et al. Among authors: skliris gp. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):139-46. doi: 10.1016/j.jsbmb.2006.09.021. Epub 2006 Nov 7. J Steroid Biochem Mol Biol. 2006. PMID: 17092701 Review.

Cite

Share

4

Cite

Share

Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.

Skliris GP, Leygue E, Watson PH, Murphy LC. Skliris GP, et al. J Steroid Biochem Mol Biol. 2008 Mar;109(1-2):1-10. doi: 10.1016/j.jsbmb.2007.12.010. Epub 2007 Dec 8. J Steroid Biochem Mol Biol. 2008. PMID: 18243688 Review.

Cite

Share

5

Cite

Share

Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.

Skliris GP, Lewis A, Emberley E, Peng B, Weebadda WK, Kemp A, Davie JR, Shiu RP, Watson PH, Murphy LC. Skliris GP, et al. Breast Cancer Res Treat. 2007 Jul;104(1):75-85. doi: 10.1007/s10549-006-9390-x. Epub 2006 Sep 29. Breast Cancer Res Treat. 2007. PMID: 17009105

Cite

Share

6

Cite

Share

Steroid receptor RNA activator protein (SRAP) expression as a prognostic factor in ER+ human breast tumors.

Yan Y, Penner CC, Skliris GP, Cooper C, Nugent Z, Blanchard A, Hamedani MK, Wang X, Myal Y, Murphy LC, Leygue E. Yan Y, et al. Among authors: skliris gp. J Cancer Res Clin Oncol. 2013 Oct;139(10):1637-47. doi: 10.1007/s00432-013-1485-2. Epub 2013 Aug 2. J Cancer Res Clin Oncol. 2013. PMID: 23907597

Cite

Share

7

Cite

Share

Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.

Skliris GP, Leygue E, Curtis-Snell L, Watson PH, Murphy LC. Skliris GP, et al. Br J Cancer. 2006 Sep 4;95(5):616-26. doi: 10.1038/sj.bjc.6603295. Epub 2006 Aug 1. Br J Cancer. 2006. PMID: 16880783 Free PMC article.

Cite

Share

8

Cite

Share

A phosphorylation code for oestrogen receptor-alpha predicts clinical outcome to endocrine therapy in breast cancer.

Skliris GP, Nugent ZJ, Rowan BG, Penner CR, Watson PH, Murphy LC. Skliris GP, et al. Endocr Relat Cancer. 2010 Jun 3;17(3):589-97. doi: 10.1677/ERC-10-0030. Print 2010 Sep. Endocr Relat Cancer. 2010. PMID: 20418363

Cite

Share

9

Cite

Share

CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.

Al-Dhaheri M, Wu J, Skliris GP, Li J, Higashimato K, Wang Y, White KP, Lambert P, Zhu Y, Murphy L, Xu W. Al-Dhaheri M, et al. Among authors: skliris gp. Cancer Res. 2011 Mar 15;71(6):2118-28. doi: 10.1158/0008-5472.CAN-10-2426. Epub 2011 Jan 31. Cancer Res. 2011. PMID: 21282336 Free PMC article.

Cite

Share

10

Cite

Share

Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor alpha (ERalpha) in tissue microarrays of ERalpha positive human breast carcinomas.

Skliris GP, Rowan BG, Al-Dhaheri M, Williams C, Troup S, Begic S, Parisien M, Watson PH, Murphy LC. Skliris GP, et al. Breast Cancer Res Treat. 2009 Dec;118(3):443-53. doi: 10.1007/s10549-008-0267-z. Epub 2008 Dec 23. Breast Cancer Res Treat. 2009. PMID: 19104930 Free PMC article.

Cite

Share